Navigation Links
Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention
Date:10/26/2010

BETHLEHEM, Pa., Oct. 26 /PRNewswire/ -- A landmark study of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices offer significantly better protection against accidental needlestick injuries (NSIs) than early generation active safety technologies such as semi-automatic (push-button) devices or those with manually sliding shields or hinged caps.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO)

This study, described in the article "Needlestick Injury Rates According to Different Types of Safety-Engineered Devices: Results of a French Multicenter Study" in the April 2010 issue of Infection Control and Hospital Epidemiology, was the first head-to-head comparison of safety-engineered devices by safety technology type. It was conducted by GERES (Groupe d'Etude sur le Risque d'Exposition des Soignants), a well-established, government-funded research group.

The study concludes that passive safety engineered devices are more effective than active devices for NSI prevention.

Among its findings, the study documents the procedure specific needlestick injury rate by safety device technology. For intravascular catheters the NSI rate for passive or fully automatic devices studied was 1.31 per 100,000 devices used, compared with 2.54 per 100,000 devices used for semi-automatic (push-button) technology and 4.34 per 100,000 devices used for manually sliding shield technology. With semi-automatic and sliding shield devices, healthcare workers can choose whether or not to operate the safety features. Passive, fully automatic devices, on the other hand, "require no input from the user" and "eliminate the need for elaborate training." Ac
'/>"/>

SOURCE B. Braun
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study
2. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
3. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
4. Positive Results From LigoCytes Norovirus Vaccine Challenge Study Presented at IDSA Annual Meeting
5. Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
6. INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine
7. Despite Potential Risk of Serious Birth Defects, New Study Finds Poor Adherence to Oral Contraception among Women on Category X Medications
8. Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007
9. Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study
10. Transcept Pharmaceuticals to Host Conference Call to Discuss Preliminary Analysis of Intermezzo® Highway Driving Study
11. IDRI Develops Novel Tuberculosis Vaccine, New Study in Science Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Research and Markets has announced ... and Surgical) Markets Worldwide 2014" report to their ... The purpose of this report is to analyze ... and Surgical) Gloves. The report discusses key players and ... Topics covered include product definitions, strategies, competitive analysis, ...
(Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
(Date:7/23/2014)... July 23, 2014  Silk Road Medical, Inc., ... treatment of intra- and extra-cranial cerebrovascular disease, announced ... to the position of Chief Technology Officer.  ... company,s Research and Development efforts across its family ... Prior to joining Silk Road Medical, Michael ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
... , , SANTA MONICA, ... the winners of the ,Give Thanks for Loved Ones, Brain Health ... the symptoms of dementia and Alzheimer,s disease. All five winners will ... to help seniors preserve their brain health and the most widely ...
... , , KNOXVILLE, Tenn., Dec. 15 ... attention with their revolutionary new technology for a simple blood ... the success of its pre-clinical trials for the ColoMarker(TM) assay, ... all aspects of its use. Via an inexpensive blood ...
Cached Medicine Technology:5 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2
(Date:7/23/2014)... 23, 2014 Four hospitals affiliated with ... in the latest ranking of the country’s best hospitals ... Released online today and slated for publication in August, ... General Hospital (AGH), Forbes Hospital, Saint Vincent Hospital and ... multiple clinical specialties. , “There is no ...
(Date:7/23/2014)... WEDNESDAY, July 23, 2014 (HealthDay News) --,Jealousy may not ... showing dogs can get downright possessive when it comes ... owners showed affection toward what was actually a stuffed ... snapping or pushing the stuffed dog aside, report researchers ... This jealous streak only surfaced when owners were attending ...
(Date:7/23/2014)... In a massive effort to catalog the ... at Dana-Farber Cancer Institute, have identified four subtypes ... molecular abnormalities. They say the new classification promises ... for the third-leading cancer killer worldwide. , In ... The Cancer Genome Atlas Research Network said they ...
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is ... Westlake, Westgate, Liberty Hill, Parmer, Balcones, and Georgetown clinics ... Orthopaedic Certified Specialist (OCS) or Sports ... DPT, OCS, Tony Lauretta, PT, DPT, OCS, Jason Brown, ... Leech, PT, DPT, OCS, and Mary Grimberg, PT, DPT, ...
(Date:7/23/2014)... 2014 A therapy combining salmon fibrin injections into ... into the brain restored voluntary motor function impaired by ... Center have found. , In a study on rodents, ... turning back the developmental clock in a molecular pathway ... and providing a scaffold so that neuronal axons at ...
Breaking Medicine News(10 mins):Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Dogs Can Get Jealous, Too 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2
... it time for all community-based doctors to turn to e-prescribing ... According to Rainu Kaushal and colleagues from the Weill Cornell ... prescribing errors up to seven-fold. Their study of ... in the Journal of General Internal Medicine , published ...
... ... renowned publication, The Leading Physicians of the World. Dr. Sood will be representing the ... dermatologists from all over the globe. , ... New York, NY (PRWEB) February 22, 2010 -- As owner of Harper Dermatology ...
... ... ... ... ...
... ... ... ... ...
... proven to enhance bone density and reduce fracture incidence ... increase risk of atypical fractures of the femur when ... research presented today at the 2010 Annual Meeting of ... Bisphosphonates are designed to slow or stop the ...
... , ... best selling author David S. Linthicum kicks off the Webinar series with Best Practices in ... ... of the Leveraging Cloud Computing Within the Modern Data Center webinar series. These media ...
Cached Medicine News:Health News:Physicians click their way to better prescriptions 2Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 2Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 3Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 4Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 5Health News:Kimberly-Clark Introduces Kleenex Hand Towels 2Health News:Kimberly-Clark Introduces Kleenex Hand Towels 3Health News:Kimberly-Clark Introduces Kleenex Hand Towels 4Health News:Kimberly-Clark Introduces Kleenex Hand Towels 5Health News:Kimberly-Clark Introduces Kleenex Hand Towels 6Health News:Quantity vs. quality: Long-term use of bone-building osteoporosis drugs 2Health News:Quantity vs. quality: Long-term use of bone-building osteoporosis drugs 3Health News:Bick Group Launches Leveraging Cloud Computing Within the Modern Data Center Webinar Series 2
... achieves a secure clot, targeted to the ... hemostasis is needed, when control of bleeding ... and cautery, is ineffective or impractical., CROSSEAL* ... of human Biologically Active Component (BAC) and ...
Mastisol Liquid Adhesive is a clear, non-irritating, and non-water-soluble liquid adhesive that secures the most difficult dressings for an extended period of time. Mastisol is 7 to 10 times stickier...
... Indermil® tissue adhesive is indicated for ... laparoscopic incisions, and trauma-induced lacerations in areas ... thoroughly-cleansed, and have easily approximated skin edges. ... tissue adhesive may act as a barrier ...
The first Ethyl-2-Cyanoacrylate tissue adhesive in a tube that is more economical than sutures!...
Medicine Products: